<DOC>
	<DOCNO>NCT01563809</DOCNO>
	<brief_summary>Basing investigator study evidence basal serum androgens decrease age , investigator hypothesize woman serum androgen certain level could population obtain benefit Luteinizing Hormone ( LH ) supplementation . The objective present study explore relationship basal serum androgen level need LH Controlled Ovarian Stimulation ( COS ) IVF .</brief_summary>
	<brief_title>Basal Androgens LH Needing Ovarian Stimulation Vitro Fertilization</brief_title>
	<detailed_description>Design : Single centre , open label , randomize control trial . - Population : Patients indication In Vitro Fertilization ( IVF ) follow criterion : - Protocol : All patient test day 3-5 cycle total Testosterone ( Te ) , Dehydroepiandrosetnodione sulphate ( DHEAS ) Androstenodione ( Δ4 ) . Samples frozen store -20ºC later analysis . FSH , LH , E2 , PRL TSH also determine . All patient follow Controlled Ovarian Stimulation IVF GnRH agonist long protocol . They randomize receive recombinant ( r ) FSH alone ( 225 IU/day ) r-FSH + r-LH ( 225+75 IU/day ) . - Sample size calculation : To detect difference 40 60 % ( Relative risk : 1.50 ) pregnancy rate ( PR ) patient low high androgen level respect mean COS protocol , confidence level 95 % ( error α=0.05 ) 80 % power ( error β=0.2 ) , 97 patient per arm need . ( n=388 patient ) . Rounding , 400 patient recruit .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>1st2nd IVF cycle Regular cycle ( 2535 day ) Age 18 42 BMI : 1829.9 LH : FSH &gt; 2 Low response background ( &lt; 5 oocyte ) Recurrent pregnancy loss Preimplantational genetic diagnosis indication Any systemic , metabolic endocrinological disorder .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>